AR121355A1 - Compuestos antivirales - Google Patents

Compuestos antivirales

Info

Publication number
AR121355A1
AR121355A1 ARP210100408A ARP210100408A AR121355A1 AR 121355 A1 AR121355 A1 AR 121355A1 AR P210100408 A ARP210100408 A AR P210100408A AR P210100408 A ARP210100408 A AR P210100408A AR 121355 A1 AR121355 A1 AR 121355A1
Authority
AR
Argentina
Prior art keywords
independently
alkyl
optionally substituted
membered heterocyclyl
alkoxy
Prior art date
Application number
ARP210100408A
Other languages
English (en)
Inventor
Gregory F Chin
Byoung Chun
- Clarke Michael Oneil Hanrahan Kwon
Bindu Goyal
Hon C Hui
Petr Jansa
Richard L Mackman
Dustin S Siegel
Hai Yang
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AR121355A1 publication Critical patent/AR121355A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente divulgación proporciona compuestos para tratar una variedad de enfermedades, tales como virus respiratorio sincitial (RSV), HRV, hMPV, Ébola, Zika, virus del Nilo Occidental, Dengue y VHC. Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable del mismo, en donde: Base es un compuesto del grupo de fórmulas (2); R¹A y R²A son cada uno independientemente: (A) alquilo C₁₋₁₂ opcionalmente sustituido con 1 a 3 R¹B, (B) heterociclilo de 3 a 6 miembros que tiene de 1 a 3 heteroátomos seleccionados independientemente de N, O y S, en donde el heterociclilo de 3 a 6 miembros es opcionalmente sustituido con 1 a 3 R¹C, o (C) fenilo, en donde cada R¹B es independientemente -OH, -NH₂, alcoxi C₁₋₆, metoxietoxi, o heterociclilo de 3 a 6 miembros que tiene de 1 a 3 heteroátomos seleccionados independientemente de N, O y S, y cada R¹C es independientemente alquilo C₁₋₃; R³ es -N(H)R³A o -N=C(R³B)(R³C); R³A es H, -CH₂OP(O)(OH)₂, o -C(O)R³D, en donde R³D es alquilo C₁₋₆ opcionalmente sustituido con 1 metoxi, o heterociclilo de 3 a 6 miembros que tiene de 1 a 3 heteroátomos seleccionados independientemente de N, O y S, opcionalmente sustituido con alquilo C₁₋₃; R³B es H o alquilo C₁₋₃; R³C es -N(R³C¹)(R³C²); R³C¹ y R³C² son cada uno independientemente H o alquilo C₁₋₆; o R³C¹ y R³C² junto con el átomo a que están unidos forman un heterociclilo de 3 a 6 miembros que tiene de 1 a 3 heteroátomos seleccionados independientemente de N, O y S, opcionalmente sustituido con alquilo C₁₋₆; R⁴A es O ó S; y R⁴B y R⁴C son cada uno independientemente (A) -OH; (B) -OR⁴B¹, en donde R⁴B¹ es alquilo C₁₋₆ opcionalmente sustituido con 1 a 3 grupos R⁴B², o arilo C₆₋₁₂, en donde cada grupo R⁴B² es independientemente alcoxi C₁₋₆, -S-R⁴B³, o -S(O)₂-R⁴B³, y cada grupo R⁴B³ es independientemente alquilo C₁₋₆; (C) un compuesto de fórmula (3), en donde m es 0, 1, 2, 3, 4, ó 5; y cada R⁴D es independientemente alquilo C₁₋₃ opcionalmente sustituido con 1 a 3 grupos R⁴D¹, alcoxi C₁₋₃ opcionalmente sustituido con 1 a 3 grupos R⁴D², o -C(O)N(R⁴D³)₂, en donde cada grupo R⁴D¹ es independientemente -NH₂ o -C(O)OR⁴D³, cada R⁴D² es independientemente alcoxi C₁₋₃, y cada R⁴D³ es independientemente alquilo C₁₋₃; (D) un compuesto de fórmula (4), en donde R⁴E¹ y R⁴E² son cada uno independientemente H o alquilo C₁₋₆, R⁴F¹ y R⁴F² son cada uno independientemente H o alquilo C₁₋₆, o R⁴F¹ y R⁴F² juntos son oxo, R⁴G es alquilo C₁₋₁₂ opcionalmente sustituido con 1 a 3 R⁴G¹, cicloalquilo C₃₋₇ opcionalmente sustituido con 1 a 3 R⁴G², heterociclilo de 3 a 8 miembros que tiene 1 a 3 heteroátomos seleccionados de N, O y S, opcionalmente sustituido con 1 a 3 R⁴G³, o -C(O)R⁴G⁴, cada R⁴G¹ es independientemente -OH, alquilo C₁₋₆, alcoxi C₁₋₃, -(CH₂OCH₂)₁₋₅-CH₃, -N(R⁴G⁸)₂, -OP(O)(OH)₂, cicloalquilo C₃₋₇ opcionalmente sustituido con 1 a 3 R⁴G⁹, heterociclilo de 3 a 6 miembros que tiene de 1 a 3 heteroátomos seleccionados independientemente de N, O y S, opcionalmente sustituido con 1 a 3 R⁴G¹⁰, o fenilo, cada R⁴G² es independientemente alquilo C₁₋₆, haloalquilo C₁₋₃, o -NH₂, cada R⁴G³ es independientemente halógeno o alquilo C₁₋₃; cada R⁴G⁴ es independientemente alquilo C₁₋₁₂, cada R⁴G⁸ es independientemente alquilo C₁₋₆, cada R⁴G⁹ es independientemente haloalquilo C₁₋₃, o -NH₂, y cada R⁴G¹⁰ es independientemente haloalquilo C₁₋₃; o (E) -(OP(O)(OH))₁₋₂-OH; y R⁵A y R⁵B son cada uno alquilo C₁₋₆ sustituido con -OP(O)(OH)₂.
ARP210100408A 2020-02-18 2021-02-17 Compuestos antivirales AR121355A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202062977881P 2020-02-18 2020-02-18

Publications (1)

Publication Number Publication Date
AR121355A1 true AR121355A1 (es) 2022-05-11

Family

ID=74859527

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100408A AR121355A1 (es) 2020-02-18 2021-02-17 Compuestos antivirales

Country Status (10)

Country Link
US (2) US11767337B2 (es)
EP (1) EP4107164A1 (es)
JP (2) JP7483023B2 (es)
KR (1) KR20220142483A (es)
CN (1) CN115087659A (es)
AR (1) AR121355A1 (es)
AU (2) AU2021221986B2 (es)
CA (1) CA3171497A1 (es)
TW (2) TW202322824A (es)
WO (1) WO2021168038A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7429799B2 (ja) 2020-02-18 2024-02-08 ギリアード サイエンシーズ, インコーポレイテッド 抗ウイルス化合物
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
WO2022166581A1 (zh) * 2021-02-07 2022-08-11 石家庄迪斯凯威医药科技有限公司 一种核苷酸衍生物及其药物组合物和用途
EP4323362A1 (en) 2021-04-16 2024-02-21 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
US12116380B2 (en) 2021-08-18 2024-10-15 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same
WO2023056936A1 (zh) * 2021-10-07 2023-04-13 南京知和医药科技有限公司 一种核苷酸衍生物及其药物组合物和用途
US20240199676A1 (en) * 2022-03-03 2024-06-20 Gilead Sciences, Inc. Antiviral compounds and methods of making and using the same
AU2023227862A1 (en) * 2022-03-03 2024-09-26 Gilead Sciences, Inc. Antiviral compounds and methods of making and using the same

Family Cites Families (485)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3565070A (en) 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
FR2224175B1 (es) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
NL7606413A (en) 1976-06-14 1977-12-16 Kowa Co Adenosine-5'-phosphoric acid derivs. and their salts - prepd. by acylating adenosine-5'-phosphate and opt. desalting or salt exchanging
DE2626792A1 (de) 1976-06-15 1977-12-29 Kowa Co Acylderivate von adenosin-5'-monophosphorsaeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
FR2354774A1 (fr) 1976-06-15 1978-01-13 Kowa Co Derives de l'acide adenosine-5'-monophosphorique et medicament contenant ces substances
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
JPS6286363A (ja) 1985-10-11 1987-04-20 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料
DE3528753A1 (de) 1985-08-10 1987-02-19 Bayer Ag Substituierte pyrazolin-5-one
US4707540A (en) 1986-10-29 1987-11-17 Morton Thiokol, Inc. Nitramine oxetanes and polyethers formed therefrom
US4871758A (en) 1987-03-18 1989-10-03 Schulman Jerome M Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
DE3711345A1 (de) 1987-04-03 1988-10-20 Bayer Ag Substituierte propylamine
IN167775B (es) 1988-06-24 1990-12-22 Hoechst India
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US4955371A (en) 1989-05-08 1990-09-11 Transtech Scientific, Inc. Disposable inhalation activated, aerosol device for pulmonary medicine
US5674998A (en) 1989-09-15 1997-10-07 Gensia Inc. C-4' modified adenosine kinase inhibitors
DE3932052A1 (de) 1989-09-26 1991-04-04 Basf Ag Oxazol- bzw. thiazolcarbonsaeureamide
EP0604409B1 (en) 1990-01-11 2004-07-14 Isis Pharmaceuticals, Inc. Oligonucleotide analogs for detecting and modulating rna activity and gene expression
YU84791A (sh) 1990-05-19 1994-06-10 Boehringer Ingelheim Kg. Biciklicni 1-aza-cikloalkalni
MY106399A (en) 1990-07-24 1995-05-30 Pfizer Cephalosporins and homologeus, preparation and pharmaceutical composition
FR2669639A1 (fr) 1990-11-27 1992-05-29 Atochem Cocatalyseur de polymerisation du propylene a base de silane et de monoether.
TW239158B (es) 1991-02-15 1995-01-21 Lubrizol Corp
DE69233690T2 (de) 1991-07-02 2008-01-24 Nektar Therapeutics, San Carlos Abgabevorrichtung für nebelförmige Medikamente
GB9202791D0 (en) 1992-02-11 1992-03-25 British Bio Technology Compounds
US5261538A (en) 1992-04-21 1993-11-16 Glaxo Inc. Aerosol testing method
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
DE4232852A1 (de) 1992-09-30 1994-03-31 Bayer Ag Imidazolinyl-pyridazine
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5446137B1 (en) 1993-12-09 1998-10-06 Behringwerke Ag Oligonucleotides containing 4'-substituted nucleotides
DE69522494T2 (de) 1994-04-14 2002-04-25 Canon K.K., Tokio/Tokyo Flüssigkristallzusammensetzung, Anzeigevorrichtung und Verfahren diese verwendend
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5681940A (en) 1994-11-02 1997-10-28 Icn Pharmaceuticals Sugar modified nucleosides and oligonucleotides
US5544647A (en) 1994-11-29 1996-08-13 Iep Group, Inc. Metered dose inhalator
US5622163A (en) 1994-11-29 1997-04-22 Iep Group, Inc. Counter for fluid dispensers
JP3822925B2 (ja) 1995-07-18 2006-09-20 興和株式会社 2’−3’−ジ−o−アシルatpの製造法
JPH09328497A (ja) 1996-04-12 1997-12-22 Yamasa Shoyu Co Ltd 4’−フルオロメチルヌクレオシド
CZ126799A3 (cs) 1996-10-16 1999-07-14 Icn Pharmaceuticals Purinové L-nukleosidy a jejich analogy a farmaceutické prostředky, které je obsahují
NZ500831A (en) 1997-06-30 2001-06-29 Icn Pharmaceuticals Method of producing tiazofurin and other C-nucleosides using a single step process wherein the cyano sugar group is converted into thiocarboxamide and subsequently condensed to form an azole ring
ES2242291T5 (es) 1997-09-12 2016-03-11 Exiqon A/S Análogos de nucleósidos bicíclicos y tricíclicos, nucleótidos y oligonucleótidos
US6150379A (en) 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
AU1608399A (en) 1997-11-26 1999-06-15 Axys Pharmaceuticals, Inc. Substituted amidinoaryl derivatives and their use as anticoagulants
US5972099A (en) 1997-12-17 1999-10-26 Bayer Corporation Process for preparing organic pigment compositions
CO5040088A1 (es) 1998-04-03 2001-05-29 Advanced Medicine Inc Nuevos compuestos y usos anestesicos locales
WO1999061583A2 (en) 1998-05-28 1999-12-02 Incara Pharmaceuticals Corp. Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
US6306895B1 (en) 1998-07-03 2001-10-23 Millenium Pharmaceuticals, Inc. Substituted oxygen alicyclic compounds, including methods for synthesis thereof
WO2000032152A2 (en) 1998-12-02 2000-06-08 Princeton University Compositions and methods for regulating bacterial pathogenesis
US6432975B1 (en) 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US6116234A (en) 1999-02-01 2000-09-12 Iep Pharmaceutical Devices Inc. Metered dose inhaler agitator
GB9908934D0 (en) 1999-04-19 1999-06-16 Rolic Ag Liquid crystalline compounds
EP1046631A1 (en) 1999-04-19 2000-10-25 Rolic AG Liquid crystalline compounds
ATE356824T1 (de) 1999-05-04 2007-04-15 Santaris Pharma As L-ribo-lna analoge
AUPQ105499A0 (en) 1999-06-18 1999-07-08 Biota Scientific Management Pty Ltd Antiviral agents
IL147281A0 (en) 1999-06-29 2002-08-14 Uab Research Foundation Methods of treating fungal infections with inhibitors of nad synthetase enzyme
DE19934799B4 (de) 1999-07-28 2008-01-24 Az Electronic Materials (Germany) Gmbh Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
EP1204645A2 (en) 1999-08-04 2002-05-15 Millennium Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
DE19939910A1 (de) 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
EP1214332A1 (en) 1999-09-17 2002-06-19 Amersham Biosciences Corp. Charge-modified nucleic acid terminators
EP1218336A2 (en) 1999-09-20 2002-07-03 Takeda Chemical Industries, Ltd. Melanin concentrating hormone antagonist
US6514964B1 (en) 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
GB9930557D0 (en) 1999-12-23 2000-02-16 Rolic Ag Optically active materials
EP1259485B1 (en) 2000-02-29 2005-11-30 Millennium Pharmaceuticals, Inc. BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
US20090124690A1 (en) 2000-04-03 2009-05-14 Alberte Randall S Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
WO2001077091A2 (en) 2000-04-05 2001-10-18 Tularik Inc. Ns5b hcv polymerase inhibitors
US6696081B2 (en) 2000-06-09 2004-02-24 Duke University Carbohydrate based lipid compositions and supramolecular structures comprising same
EP1170353B1 (en) 2000-07-06 2005-11-02 Fuji Photo Film Co., Ltd. Liquid crystal composition comprising liquid crystal molecules and aligment promoter
EP1301074A2 (en) 2000-07-14 2003-04-16 The UAB Research Foundation Uses for nad synthetase inhibitors
AU2001279955A1 (en) 2000-08-18 2002-03-04 Sterix Limited 2-substituted estradiol derivative for inhibiting superoxid dismutase
AU2001294865A1 (en) 2000-09-30 2002-04-15 Loctite Low shrinkage thermosetting resin compositions and methods of use therefor
IL155202A0 (en) 2000-10-20 2003-11-23 Biocryst Pharm Inc Biaryl compounds as serine protease inhibitors
AUPR105700A0 (en) 2000-10-27 2000-11-23 Monash University Process for preparation of bicyclic and polycyclic molecules
WO2002039987A2 (en) 2000-11-14 2002-05-23 Neurosearch A/S Use of malaria parasite anion channel blockers for treating malaria
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
DE10064823A1 (de) 2000-12-22 2002-06-27 Knoll Ag Integrinrezeptorliganden
EP1363890A4 (en) 2001-02-07 2009-06-10 Ore Pharmaceuticals Inc MELANOCORTIN-4-RECEPTOR BINDING COMPOUNDS AND METHOD FOR THEIR APPLICATION
JP2002326996A (ja) 2001-03-02 2002-11-15 Toray Ind Inc 光学活性体の製造法
JP4161291B2 (ja) 2001-03-02 2008-10-08 東レ・ファインケミカル株式会社 光学活性体の製造法
JP4342178B2 (ja) 2001-04-06 2009-10-14 バイオクリスト・ファマシューティカルズ インク. セリンプロテアーゼ阻害剤としてのビアリール化合物
US20030170891A1 (en) 2001-06-06 2003-09-11 Mcswiggen James A. RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
EP1572067A4 (en) 2001-05-18 2009-05-13 Sirna Therapeutics Inc CONJUGATES AND COMPOSITIONS FOR CELL DELIVERY
US20030175950A1 (en) 2001-05-29 2003-09-18 Mcswiggen James A. RNA interference mediated inhibition of HIV gene expression using short interfering RNA
GB0114286D0 (en) 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
WO2004043335A2 (en) 2001-09-13 2004-05-27 Genesoft, Inc. Methods of treating infection by drug resistant bacteria
AU2002351077A1 (en) 2001-11-05 2003-05-19 Exiqon A/S Oligonucleotides modified with novel alpha-l-rna analogues
WO2003041649A2 (en) 2001-11-13 2003-05-22 Merck Frosst Canada & Co. Cyanoalkylamino derivatives as protease inhibitors
CA2469336C (en) 2001-12-11 2013-06-11 The Board Of Trustees Of The Leland Stanford Junior University Guanidinium transport reagents and conjugates
JP2003246770A (ja) 2002-02-25 2003-09-02 Toray Ind Inc 光学活性体の製造法
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
AU2003225156A1 (en) 2002-04-24 2003-11-10 Symyx Technologies, Inc. Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom
EP1498125A4 (en) 2002-04-24 2008-08-20 Takeda Pharmaceutical USE OF ANTI-CCR ANTAGONISM COMPOUNDS
TW200500374A (en) 2002-06-28 2005-01-01 Idenlx Cayman Ltd 2' and 3' -nucleoside produrgs for treating flavivridae infections
US20060004010A1 (en) 2002-07-10 2006-01-05 Hiromu Habashita Ccr4 antagonist and medical use thereof
WO2004014312A2 (en) 2002-08-08 2004-02-19 Sirna Therapeutics, Inc. Small-mer compositions and methods of use
WO2004037159A2 (en) 2002-10-23 2004-05-06 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
US20040229840A1 (en) 2002-10-29 2004-11-18 Balkrishen Bhat Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
US20040146941A1 (en) 2002-11-04 2004-07-29 Biliang Zhang Chemical encoding technology for combinatorial synthesis
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
MXPA05009771A (es) 2003-03-14 2005-10-26 Ono Pharmaceutical Co Derivados heterociclicos que contienen nitrogeno y medicamentos que los contienen como el ingrediente activo.
US7135469B2 (en) 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
GB0306430D0 (en) 2003-03-20 2003-04-23 Bp Chem Int Ltd Polymerisation and oligomerisation catalysts
ES2423800T3 (es) 2003-03-28 2013-09-24 Novartis Vaccines And Diagnostics, Inc. Uso de compuestos orgánicos para la inmunopotenciación
EP1613261A4 (en) 2003-04-09 2011-01-26 Novo Nordisk As INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
JP2004315613A (ja) 2003-04-14 2004-11-11 Fuji Photo Film Co Ltd セルロースアシレートフィルム、その製造方法、偏光板保護膜、液晶表示装置、及びハロゲン化銀写真感光材料
US7268133B2 (en) 2003-04-23 2007-09-11 Pfizer, Inc. Patent Department Cannabinoid receptor ligands and uses thereof
US20040229839A1 (en) 2003-05-14 2004-11-18 Biocryst Pharmaceuticals, Inc. Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
CN102584813B (zh) 2003-05-14 2016-07-06 Ngc药物公司 化合物及其在调节淀粉样蛋白β中的用途
WO2005020885A2 (en) 2003-05-21 2005-03-10 Isis Pharmaceuticals, Inc. Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
WO2004106356A1 (en) 2003-05-27 2004-12-09 Syddansk Universitet Functionalized nucleotide derivatives
WO2005021568A2 (en) 2003-08-27 2005-03-10 Biota, Inc. Novel tricyclic nucleosides or nucleotides as therapeutic agents
JPWO2005023771A1 (ja) 2003-09-05 2006-11-02 小野薬品工業株式会社 ケモカインレセプターアンタゴニストおよびその医薬用途
WO2005025515A2 (en) 2003-09-12 2005-03-24 California Institute Of Technology Proteasome pathway inhibitors and related methods
JP4231379B2 (ja) 2003-10-15 2009-02-25 富士フイルム株式会社 潤滑剤組成物
EP1679309A4 (en) 2003-10-24 2007-03-28 Ono Pharmaceutical Co ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
AU2004299174A1 (en) 2003-12-10 2005-06-30 Merck Patent Gmbh Diacylhydrazine derivatives
WO2005093476A1 (en) 2004-03-25 2005-10-06 Fuji Photo Film Co., Ltd. Transparent film and optical compensatory film, polarizing plate and liquid-crystal display device employing it
WO2005095544A1 (en) 2004-03-25 2005-10-13 Merck Patent Gmbh Liquid crystal compounds, liquid crystal medium and liquid crystal display
US7306631B2 (en) 2004-03-30 2007-12-11 The Procter & Gamble Company Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
EP1593713A1 (en) 2004-05-04 2005-11-09 Rolic AG Polymerizable dichromophoric dichroic azo dyes
GB0410604D0 (en) 2004-05-12 2004-06-16 Bp Chem Int Ltd Ethylene copolymers
PT1765360E (pt) * 2004-06-14 2009-12-24 Anacor Pharmaceuticals Inc Utilizações antivirais de complexos de ácido borínico
WO2006001463A1 (ja) 2004-06-23 2006-01-05 Ono Pharmaceutical Co., Ltd. S1p受容体結合能を有する化合物およびその用途
WO2006006490A1 (ja) 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
GB0415879D0 (en) 2004-07-15 2004-08-18 Bp Chem Int Ltd Polymerisation catalyst
GB0418022D0 (en) 2004-08-12 2004-09-15 Bp Chem Int Ltd Polymerisation and oligomerisation catalyst
GB0420396D0 (en) 2004-09-14 2004-10-13 Bp Chem Int Ltd Polyolefins
WO2006038594A1 (ja) 2004-10-04 2006-04-13 Ono Pharmaceutical Co., Ltd. N型カルシウムチャネル阻害薬
GB0424422D0 (en) 2004-11-04 2004-12-08 Bp Chem Int Ltd Polymerisation catalysts
JP4429149B2 (ja) 2004-11-26 2010-03-10 キヤノン株式会社 フルオレン化合物及び有機発光素子
WO2006061094A1 (en) 2004-12-11 2006-06-15 Merck Patent Gmbh Liquid crystal compounds, liquid crystal medium and liquid crystal display
EP1828217A2 (en) 2004-12-16 2007-09-05 Febit Biotech GmbH Polymerase-independent analysis of the sequence of polynucleotides
EP1831235B1 (en) 2004-12-16 2013-02-20 The Regents of The University of California Lung-targeted drugs
JP4749000B2 (ja) 2005-02-22 2011-08-17 富士フイルム株式会社 グリース組成物
US7622240B2 (en) 2005-02-28 2009-11-24 International Business Machines Corporation Low blur molecular resist
AU2006222563A1 (en) 2005-03-08 2006-09-14 Biota Scientific Management Pty Ltd. Bicyclic nucleosides and nucleotides as therapeutic agents
EP1867704B1 (en) 2005-03-15 2010-09-15 FUJIFILM Corporation Surface treatment method using disc-like compound, (lubricating) composition for surface treatment, and surface-treated article
US20060229265A1 (en) 2005-03-30 2006-10-12 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
US20090156545A1 (en) 2005-04-01 2009-06-18 Hostetler Karl Y Substituted Phosphate Esters of Nucleoside Phosphonates
WO2006110656A2 (en) 2005-04-08 2006-10-19 Chimerix, Inc. Compounds, compositions and methods for the treatment of viral infections and other medical disorders
WO2006119800A1 (en) 2005-05-09 2006-11-16 Technische Universität Braunschweig Light emitting compound for electroluminescent applications
US7576205B2 (en) 2005-06-13 2009-08-18 Agency For Science, Technology & Research Detectable threading intercalator
WO2007007588A1 (ja) 2005-07-08 2007-01-18 Ono Pharmaceutical Co., Ltd. 平面性を有する環状基を母核とする化合物
WO2007011759A2 (en) 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
JP2007056213A (ja) 2005-08-26 2007-03-08 Fujifilm Corp 焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
DE102005043165A1 (de) 2005-09-12 2007-03-22 Merck Patent Gmbh Metallkomplexe
EP1945222B1 (en) 2005-11-02 2012-12-26 Bayer Pharma Aktiengesellschaft Pyrrolo[2,1-f] [1,2,4]-triazin-4-ylamines as igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
EP1942732A2 (en) 2005-11-02 2008-07-16 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
US7910595B2 (en) 2005-12-21 2011-03-22 Abbott Laboratories Anti-viral compounds
US20070208053A1 (en) 2006-01-19 2007-09-06 Arnold Lee D Fused heterobicyclic kinase inhibitors
DE602007008837D1 (de) 2006-02-14 2010-10-14 Vertex Pharma Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
AR060095A1 (es) 2006-03-29 2008-05-21 Schering Corp Derivados de himbacina monociclicos y biciclicos utiles como antogonistas de los receptores de trombina
WO2007125320A1 (en) 2006-04-25 2007-11-08 Astex Therapeutics Limited Pharmaceutical compounds
US7749983B2 (en) 2006-05-03 2010-07-06 Chimerix, Inc. Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
EP2035395A2 (en) 2006-06-27 2009-03-18 Glenmark Pharmaceuticals S.A. Novel processes for the preparation of dpp iv inhibitors
JP2008007634A (ja) 2006-06-29 2008-01-17 Fujifilm Corp 潤滑剤組成物
EP2044061A2 (en) 2006-07-20 2009-04-08 Mehmet Kahraman Benzothiophene inhibitors of rho kinase
GB0614947D0 (en) 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy
PE20080906A1 (es) 2006-08-17 2008-07-05 Kemia Inc Derivados heteroarilo como inhibidores de citocina
CA2659465A1 (en) 2006-08-22 2008-02-28 Redpoint Bio Corporation Heterocyclic compounds as sweetener enhancers
US7951789B2 (en) 2006-12-28 2011-05-31 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
NZ578556A (en) 2007-01-12 2012-04-27 Biocryst Pharm Inc Antiviral nucleoside analogs
US20090016990A1 (en) 2007-01-24 2009-01-15 Alberte Randall S Antimicrobial Compositions
AU2008210411A1 (en) 2007-01-31 2008-08-07 Alios Biopharma, Inc. 2-5A derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
JP2010520293A (ja) 2007-03-07 2010-06-10 アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド 複素環式部分を含有するメタロプロテアーゼ阻害剤
US8088566B2 (en) 2007-03-26 2012-01-03 Fujifilm Corporation Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent
WO2008117047A1 (en) 2007-03-27 2008-10-02 Astrazeneca Ab Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
US7956020B2 (en) 2007-03-29 2011-06-07 Fujifilm Corporation Lubricant composition, mechanical element, and method for producing triazine derivatives
US8088940B2 (en) 2007-03-30 2012-01-03 Momentive Performance Materials Inc. Hydrolyzable silanes of low VOC-generating potential and resinous compositions containing same
US20120010170A1 (en) 2007-04-27 2012-01-12 Painter George R "Methods of Reducing Nephrotoxicity in Subjects Administered Nucleoside Phosphonates"
ES2393038T3 (es) 2007-05-10 2012-12-18 Biocryst Pharmaceuticals, Inc. Compuestos de tretrahidrofuro[3,4-D]dioxolano para su utlilización en el tratamiento de las infecciones víricas y del cáncer
US20110319459A1 (en) 2007-06-14 2011-12-29 Osta Biotechnologies Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
CA2727528A1 (en) 2007-06-14 2008-12-18 Osta Biotechnologies Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
GB0712494D0 (en) 2007-06-27 2007-08-08 Isis Innovation Substrate reduction therapy
CN100532388C (zh) 2007-07-16 2009-08-26 郑州大学 2’-氟-4’-取代-核苷类似物、其制备方法及应用
KR101526024B1 (ko) 2007-07-19 2015-06-04 코니카 미놀타 어드밴스드 레이어즈 인코포레이티드 셀룰로오스 에스테르 필름, 셀룰로오스 에스테르 필름의 제조 방법, 그것을 사용한 편광판 및 액정 표시 장치
JP5604872B2 (ja) 2007-07-19 2014-10-15 コニカミノルタ株式会社 セルロースエステルフィルム
US9340506B2 (en) 2007-10-08 2016-05-17 Advinus Therapeutics Limited Acetamide derivatives as glucokinase activators, their process and medicinal applications
US20090318380A1 (en) 2007-11-20 2009-12-24 Pharmasset, Inc. 2',4'-substituted nucleosides as antiviral agents
AR069740A1 (es) 2007-11-29 2010-02-17 Metabasis Therapeutics Inc Compuestos nucleosidos antivirales
JP5637859B2 (ja) 2007-12-13 2014-12-10 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated 嚢胞性線維症膜コンダクタンスレギュレーターのモジュレーター
US20090181921A1 (en) 2007-12-21 2009-07-16 Alios Biopharma Inc. 2-5a analogs and their methods of use
WO2009086192A1 (en) 2007-12-21 2009-07-09 Alios Biopharma, Inc. Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents
TW200942243A (en) 2008-03-05 2009-10-16 Biocryst Pharm Inc Antiviral therapeutic agents
EP2098226A1 (de) 2008-03-06 2009-09-09 Forschungsverbund Berlin e.V. AKAP-PKA-Interaktionshemmer zur Anwendung in der Behandlung von Herzkrankheiten
ES2398684T3 (es) 2008-04-23 2013-03-21 Gilead Sciences, Inc. Análogos de carbanucleósido para el tratamiento antiviral
WO2010036407A2 (en) 2008-05-15 2010-04-01 Biocryst Pharmaceuticals, Inc. Antiviral nucleoside analogs
JP5712125B2 (ja) 2008-05-27 2015-05-07 トリリンク バイオテクノロジーズ 高温で開始される核酸増幅のための、化学修飾されたヌクレオシド5’−三リン酸
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US7910020B2 (en) 2008-06-27 2011-03-22 Transitions Optical, Inc. Liquid crystal compositions comprising mesogen containing compounds
US7910019B2 (en) 2008-06-27 2011-03-22 Transitions Optical, Inc. Mesogen containing compounds
US8628685B2 (en) 2008-06-27 2014-01-14 Transitions Optical, Inc Mesogen-containing compounds
US7803285B2 (en) 2008-07-01 2010-09-28 Gentex Corporation Liquid crystal display device and associated liquid crystal media for use in the same
WO2010002877A2 (en) 2008-07-03 2010-01-07 Biota Scientific Management Bycyclic nucleosides and nucleotides as therapeutic agents
GB0812297D0 (en) 2008-07-04 2008-08-13 Lucite Int Uk Ltd Novel carbonylation ligand sand thier use of in the carbonylation of ethylenically unsaturated compounds
UY31982A (es) 2008-07-16 2010-02-26 Boehringer Ingelheim Int Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
GB0815968D0 (en) 2008-09-03 2008-10-08 Angeletti P Ist Richerche Bio Antiviral agents
JP5295692B2 (ja) 2008-09-10 2013-09-18 豊和工業株式会社 自動開閉防音サッシ
CA2737661C (en) 2008-09-23 2019-08-20 Alnylam Pharmaceuticals, Inc. Chemical modifications of monomers and oligonucleotides with cycloaddition
US20100096603A1 (en) 2008-10-20 2010-04-22 Nitto Denko Corporation Optical devices responsive to near infrared laser and methods of modulating light
AR074231A1 (es) 2008-11-27 2010-12-29 Boehringer Ingelheim Int Derivados de 6, 7, 8, 9-tetrahidro-5h-1, 4, 7, 10a-tetraaza-ciclohept[f]indeno, composiciones farmacéuticas que contienen estos compuestos, su uso en el agonismo del receptor 5-ht2c y procesos para prepararlos.
WO2010073126A2 (en) 2008-12-22 2010-07-01 The Governors Of The University Of Alberta Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
GB0900914D0 (en) 2009-01-20 2009-03-04 Angeletti P Ist Richerche Bio Antiviral agents
US9040718B2 (en) 2009-01-22 2015-05-26 The University Of Rochester Hybrid host materials for electrophosphorescent devices
KR20100087540A (ko) 2009-01-28 2010-08-05 삼성전자주식회사 잉크젯 기록용 잉크 조성물
EA201190178A1 (ru) 2009-03-20 2012-06-29 Алиос Биофарма, Инк. Замещённые нуклеозидные и нуклеотидные аналоги
WO2010108135A1 (en) 2009-03-20 2010-09-23 Alios Biopharma, Inc. Protected nucleotide analogs
EP2264169A1 (en) 2009-06-15 2010-12-22 Qiagen GmbH Modified siNA
US20110212994A1 (en) 2009-06-26 2011-09-01 Brian Clem Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
US8927513B2 (en) 2009-07-07 2015-01-06 Alnylam Pharmaceuticals, Inc. 5′ phosphate mimics
WO2011016430A1 (ja) 2009-08-04 2011-02-10 三菱化学株式会社 光電変換素子及びこれを用いた太陽電池
AU2010281265A1 (en) 2009-08-05 2012-03-22 Versitech Limited Antiviral compounds and methods of making and using thereof
NZ598808A (en) 2009-09-09 2014-07-25 Celgene Avilomics Res Inc Pi3 kinase inhibitors and uses thereof
CA2773561A1 (en) 2009-09-14 2011-03-17 Phusis Therapeutics Inc. Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
US8455451B2 (en) 2009-09-21 2013-06-04 Gilead Sciences, Inc. 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
MX2012003126A (es) 2009-09-21 2012-06-19 Gilead Sciences Inc Procesos e intermedios para la preparacion de analogos de 1'-carbonucleosidos sustituidos.
EP2480552B1 (en) 2009-09-21 2016-11-09 Gilead Sciences, Inc. 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
US20120264810A1 (en) 2009-09-22 2012-10-18 The University Of British Columbia Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles
WO2011038207A1 (en) 2009-09-25 2011-03-31 Metabasis Therapeutics, Inc. Phosphorus-containing thyroid hormone receptor agonists and methods of use
DE102010035730A1 (de) 2009-09-28 2011-04-07 Merck Patent Gmbh Polymerisierbare Verbindungen und ihre Verwendung in Flüssigkristallanzeigen
WO2011057214A2 (en) 2009-11-09 2011-05-12 Neurogenetic Pharmaceuticals, Inc. Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
CN102000103B (zh) 2009-12-21 2011-12-21 郑州大学 2’-氟-4’-叠氮-核苷类似物或其盐的药物应用
TWI485153B (zh) 2010-01-13 2015-05-21 Sanofi Aventis 2,5,7-經取代唑并嘧啶衍生物
US9198972B2 (en) 2010-01-28 2015-12-01 Alnylam Pharmaceuticals, Inc. Monomers and oligonucleotides comprising cycloaddition adduct(s)
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
JP5816635B2 (ja) 2010-03-05 2015-11-18 カリオファーム セラピューティクス,インコーポレイテッド 核輸送調節剤およびその使用
EP2550260A1 (en) 2010-03-24 2013-01-30 Medical University Of South Carolina Compositions and methods for the treatment of degenerative diseases
US20110312996A1 (en) 2010-05-17 2011-12-22 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
FR2960235B1 (fr) 2010-05-18 2013-11-01 Inst Francais Du Petrole Procede d'oligomerisation des olefines utilisant une composition comprenant un complexe organometallique contenant un ligand alcoxy fonctionnalise par un hetero-atome.
FR2960234B1 (fr) 2010-05-18 2013-11-01 Inst Francais Du Petrole Procede de dimerisation de l'ethylene en butene-1 utilisant une composition comprenant un complexe a base de titane et un ligand alcoxy fonctionnalise par un hetero-atome.
TW201201815A (en) 2010-05-28 2012-01-16 Gilead Sciences Inc 1'-substituted-carba-nucleoside prodrugs for antiviral treatment
WO2011156632A2 (en) 2010-06-09 2011-12-15 Georgetown University Compositions and methods of treatment for tumors in the nervous system
US8614021B2 (en) 2010-06-10 2013-12-24 The United States Of America As Represented By The Secretary Of The Army Agents for enhanced charge transport across microbial membranes
BR112013001267A2 (pt) 2010-07-19 2016-05-17 Gilead Sciences Inc métodos para a preparação de pró-fármacos de fosforamidato diasteromericamente puro
US20120027752A1 (en) 2010-07-22 2012-02-02 Gilead Sciences, Inc. Methods and compounds for treating paramyxoviridae virus infections
CN102351931B (zh) 2010-09-07 2014-01-22 河南省科学院高新技术研究中心 嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
TW201305185A (zh) 2010-09-13 2013-02-01 Gilead Sciences Inc 用於抗病毒治療之2’-氟取代之碳-核苷類似物
DE102010045369A1 (de) 2010-09-14 2012-03-15 Merck Patent Gmbh Materialien für organische Elektrolumineszenzvorrichtungen
WO2012040126A1 (en) 2010-09-22 2012-03-29 Alios Biopharma, Inc. Substituted nucleotide analogs
CN103209987B (zh) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 取代的核苷酸类似物
ES2701020T3 (es) 2010-09-22 2019-02-20 Alios Biopharma Inc Nucleósidos azido y análogos nucleotídicos
WO2012068340A2 (en) 2010-11-18 2012-05-24 Opko Curna Llc Antagonat compositions and methods of use
WO2012083048A2 (en) 2010-12-15 2012-06-21 Abbott Laboratories Anti-viral compounds
AU2011349844B2 (en) 2010-12-20 2017-06-01 Gilead Sciences, Inc. Combinations for treating HCV
EP2655334B1 (en) 2010-12-22 2018-10-03 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
CA2819041A1 (en) 2010-12-22 2012-06-28 Alios Biopharma, Inc. Cyclic nucleotide analogs
TWI450891B (zh) 2010-12-29 2014-09-01 Dev Center Biotechnology 新穎微管蛋白抑制劑
US20120219568A1 (en) 2011-02-24 2012-08-30 Zhejiang University Epidithiodioxopiprazines and uses thereof in treating cancer
AU2012223528A1 (en) 2011-03-02 2013-10-24 Joseph M. Fayad Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infection
WO2012121973A1 (en) 2011-03-04 2012-09-13 Life Technologies Corporation Compounds and methods for conjugation of biomolecules
BR112013023681A2 (pt) 2011-03-16 2016-12-13 Hoffmann La Roche compostos de álcool propargílico 6,5-heterocíclico e uso dos mesmos
JP2012216832A (ja) 2011-03-30 2012-11-08 Mitsubishi Chemicals Corp 光電変換素子、太陽電池、太陽電池モジュール及びインク
JP2014510155A (ja) 2011-04-06 2014-04-24 ザ トラスティーズ オブ プリンストン ユニバーシティ 抗ウイルス組み合わせ治療薬
EP2697242B1 (en) 2011-04-13 2018-10-03 Merck Sharp & Dohme Corp. 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
BR112013026219A2 (pt) 2011-04-13 2016-07-26 Gilead Sciences Inc análogos de n-nucleosídeo 1'-substituída pirimidina para tratamento antiviral
KR20130138840A (ko) 2011-04-13 2013-12-19 머크 샤프 앤드 돔 코포레이션 2''-치환된 뉴클레오시드 유도체 및 바이러스성 질환의 치료를 위한 그의 사용 방법
GB201108825D0 (en) 2011-05-25 2011-07-06 Univ Dundee Morpholino compounds, uses and methods
US20130018011A1 (en) 2011-06-10 2013-01-17 Hassan Javanbakht Method of treating dengue fever
WO2013000855A1 (en) 2011-06-30 2013-01-03 Santaris Pharma A/S Hcv combination therapy
FR2977586B1 (fr) 2011-07-08 2013-07-12 Rhodia Operations Procede de fabrication de composes comprenant des fonctions nitriles
WO2013033268A2 (en) 2011-08-29 2013-03-07 Coferon, Inc. Bivalent bromodomain ligands, and methods of using same
CN104039784B (zh) 2011-09-02 2017-08-22 拜耳知识产权有限责任公司 取代的增环嘧啶及其用途
CN102286047A (zh) 2011-09-14 2011-12-21 郑州大学 2’-脱氧-2’-氟-4’-三氮唑取代-β-D胞苷类似物、其制备方法及其应用
UA116087C2 (uk) 2011-09-16 2018-02-12 Гіліад Фармассет Елелсі Композиція для лікування вірусу гепатиту c
JP2014530195A (ja) 2011-09-16 2014-11-17 アッヴィ・インコーポレイテッド Hcvを治療するための方法
WO2013044030A1 (en) 2011-09-23 2013-03-28 Enanta Pharmaceuticals, Inc. 2'-chloroacetylenyl substituted nucleoside derivatives
WO2013056132A2 (en) 2011-10-14 2013-04-18 Stc.Unm Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
FR2982858B1 (fr) 2011-11-18 2013-11-29 Rhodia Operations Procede de fabrication de composes comprenant des fonctions nitriles
WO2013090420A2 (en) 2011-12-12 2013-06-20 Catabasis Pharmaceuticals, Inc. Fatty acid antiviral conjugates and their uses
FR2984322B1 (fr) 2011-12-16 2013-12-20 Rhodia Operations Procede de fabrication de composes comprenant des fonctions nitriles
AU2012358804B2 (en) 2011-12-22 2018-04-19 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
SG11201402826YA (en) 2011-12-22 2014-12-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
WO2013101552A1 (en) 2011-12-28 2013-07-04 Abbvie Inc. Methods for treating hcv
CN102603836A (zh) 2012-02-10 2012-07-25 郑州大学 五味子丙素简化物、类似物及其制备方法和应用
JP6242378B2 (ja) 2012-03-13 2017-12-06 ギリアード サイエンシーズ, インコーポレイテッド 抗ウイルス処置のための2’−置換カルバヌクレオシド類似体
TWI635111B (zh) 2012-03-16 2018-09-11 馬克專利公司 共軛聚合物
WO2013142159A1 (en) 2012-03-21 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
WO2013142124A1 (en) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
PL2827875T3 (pl) 2012-03-21 2019-07-31 Janssen Biopharma, Inc. Podstawione nukleozydy, nukleotydy i ich analogi
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
CN104204009B (zh) 2012-03-29 2016-08-17 英派尔科技开发有限公司 二氧杂硼烷共聚物及其应用
US20150057243A1 (en) 2012-04-02 2015-02-26 Northern University Compositions and Methods for the Inhibition of Methyltransferases
JP2013237721A (ja) 2012-05-11 2013-11-28 Nitto Denko Corp 再剥離用水分散型アクリル系粘着剤組成物、及び粘着シート
JP2015529689A (ja) 2012-06-04 2015-10-08 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 有機半導体
US9682970B2 (en) 2012-06-29 2017-06-20 Biotium, Inc. Fluorescent compounds and uses thereof
CN104583224A (zh) 2012-07-03 2015-04-29 百时美施贵宝公司 制备用于治疗病毒感染的核苷化合物的富含非对映体的氨基磷酸酯衍生物的方法
US9682958B2 (en) 2012-07-23 2017-06-20 Merck Patent Gmbh Ligands and their preparation
US20140038991A1 (en) 2012-08-06 2014-02-06 Astar Biotech Llc Protein Kinase Inhibitors
US20150284422A1 (en) 2012-08-10 2015-10-08 Epizyme, Inc. Inhibitors of protein methyltransferase dot1l and methods of use thereof
WO2014031872A2 (en) 2012-08-23 2014-02-27 The Broad Institute, Inc. Small molecule inhibitors for treating parasitic infections
WO2014035140A2 (en) 2012-08-30 2014-03-06 Kainos Medicine, Inc. Compounds and compositions for modulating histone methyltransferase activity
EP2712868A1 (en) 2012-09-28 2014-04-02 B. Braun Melsungen AG 5-Fluoruoracil Derivatives
US10513534B2 (en) 2012-10-08 2019-12-24 Idenix Pharmaceuticals Llc 2′-chloro nucleoside analogs for HCV infection
DE102012109685A1 (de) 2012-10-11 2014-04-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Umwandlung reaktiver Gruppen an Si-C-gebundenen Resten von Silanen unter gleichzeitiger Vergrößerung von deren räumlichem Abstand zueinander
US9242988B2 (en) * 2012-10-17 2016-01-26 Merck Sharp & Dohme Corp. 2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
US9457039B2 (en) 2012-10-17 2016-10-04 Merck Sharp & Dohme Corp. 2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
KR20120135501A (ko) 2012-10-29 2012-12-14 에스에프씨 주식회사 축합환 화합물 및 이를 포함한 유기 발광 소자
JP6463273B2 (ja) 2012-12-14 2019-01-30 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 複屈折rmレンズ
SG11201504554UA (en) 2012-12-21 2015-07-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
WO2014100498A1 (en) 2012-12-21 2014-06-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
FR2999917B1 (fr) 2012-12-26 2017-06-23 Oreal Polymere a empreinte moleculaire pour pieger selectivement les molecules odorantes
US20140200215A1 (en) 2013-01-15 2014-07-17 Intermune, Inc. Lysophosphatidic acid receptor antagonists
JP6024479B2 (ja) 2013-01-28 2016-11-16 コニカミノルタ株式会社 光学フィルム、円偏光板および画像表示装置
WO2014124458A1 (en) 2013-02-11 2014-08-14 The Regents Of The University Of California Compositions and methods for treating neurodegenerative diseases
US9580400B2 (en) 2013-02-26 2017-02-28 Northeastern University Cannabinergic nitrate esters and related analogs
US20150065439A1 (en) 2013-02-28 2015-03-05 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions
US20140309413A1 (en) 2013-03-11 2014-10-16 Vertex Pharmaceuticals Incorporated Methods of stereoselective synthesis of substituted nucleoside analogs
US9790291B2 (en) 2013-03-14 2017-10-17 Formosa Plastics Corporation, Usa Non-phthalate compounds as electron donors for polyolefin catalysts
JP6329764B2 (ja) 2013-03-15 2018-05-23 信越化学工業株式会社 対称ハイパーブランチ型シリコーン変性重合性化合物、及びそのモジュール化した製造方法
JP2016518316A (ja) 2013-03-15 2016-06-23 セルジーン アビロミクス リサーチ, インコーポレイテッド Mk2阻害剤およびそれらの使用
TW201542578A (zh) 2013-06-26 2015-11-16 Alios Biopharma Inc 經取代之核苷、核苷酸及其類似物
WO2015003146A1 (en) 2013-07-03 2015-01-08 Georgetown University Boronic acid derivatives of resveratrol for activating deacetylase enzymes
WO2015006280A1 (en) 2013-07-10 2015-01-15 Vertex Pharmaceuticals Incorporated Fused piperidine amides as modulators of ion channels
CN104086612A (zh) 2013-07-17 2014-10-08 郑州大学 4-取代胺基-2′-脱氧-2′-氟-4′-叠氮-β-D-胞苷类核苷化合物、制备方法及其应用
WO2015016187A1 (ja) 2013-07-29 2015-02-05 富士フイルム株式会社 非水二次電池用電解液および非水二次電池
US11383266B2 (en) 2013-08-19 2022-07-12 Queen's University At Kingston Carbene-functionalized composite materials
CA2922703A1 (en) 2013-08-29 2015-03-05 Baylor College Of Medicine Compositions and methods for the treatment of metabolic and body weight related disorders
HRP20220911T1 (hr) 2013-09-11 2022-10-28 Emory University Sastav nukleotida i nukleozida i njihova uporaba
US20160257657A1 (en) 2013-09-20 2016-09-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
KR101628288B1 (ko) 2013-09-30 2016-06-08 주식회사 엘지화학 음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
WO2015051169A2 (en) 2013-10-02 2015-04-09 Moderna Therapeutics, Inc. Polynucleotide molecules and uses thereof
SG10201804835VA (en) 2013-10-11 2018-07-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
MX2016005393A (es) 2013-10-25 2016-08-11 Abbvie Inc Metodos para tratar vhc.
UA119050C2 (uk) 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
US20150167017A1 (en) 2013-12-13 2015-06-18 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
CN103709220B (zh) 2014-01-13 2016-02-17 河南省科学院高新技术研究中心 3-甲基尿苷及4-甲基胞苷核苷类化合物、合成方法及其药物用途
EP2896678B1 (en) 2014-01-21 2018-10-17 Merck Patent GmbH Liquid crystal display
MA39317A1 (fr) 2014-02-06 2018-01-31 Riboscience Llc Dérivés de nucléosides à substitution 4'-difluorométhyle utilisés en tant qu'inhibiteurs de la réplication de l'arn du virus de la grippe
JP6144215B2 (ja) 2014-02-07 2017-06-07 富士フイルム株式会社 光電変換素子およびその使用方法、光センサ、並びに、撮像素子
WO2015129672A1 (ja) 2014-02-27 2015-09-03 Dic株式会社 液晶表示装置
EP3730590A1 (de) 2014-03-10 2020-10-28 Merck Patent GmbH Flüssigkristalline medien mit homöotroper ausrichtung
WO2015143712A1 (en) 2014-03-28 2015-10-01 Merck Sharp & Dohme Corp. 4'-substituted nucleoside reverse transcriptase inhibitors
US9399637B2 (en) 2014-03-28 2016-07-26 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
EP3131538B1 (en) 2014-04-15 2019-12-18 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO New anti-clostridium compounds
EP3157572A4 (en) 2014-06-19 2018-02-14 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
EP3157573A4 (en) 2014-06-19 2018-02-21 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
US20170136132A1 (en) 2014-06-19 2017-05-18 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
WO2015198915A1 (ja) 2014-06-23 2015-12-30 Dic株式会社 重合性液晶組成物及び該組成物を用いて作製した光学異方体、位相差膜、位相差パターニング膜
TN2016000566A1 (en) 2014-06-24 2018-04-04 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
WO2015200219A1 (en) 2014-06-24 2015-12-30 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
CN107974256A (zh) 2014-07-15 2018-05-01 Dic株式会社 液晶显示装置和聚合性液晶组合物
TWI678369B (zh) 2014-07-28 2019-12-01 美商基利科學股份有限公司 用於治療呼吸道合胞病毒感染之噻吩並[3,2-d]嘧啶、呋喃並[3,2-d]嘧啶及吡咯並[3,2-d]嘧啶化合物類
KR102289820B1 (ko) 2014-08-01 2021-08-17 삼성전자주식회사 축합환 화합물 및 이를 포함한 유기 발광 소자
WO2016029186A1 (en) 2014-08-22 2016-02-25 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent materials as co-host materials for fluorescent oleds
EP2990461B1 (en) 2014-08-25 2018-09-19 Merck Patent GmbH Liquid crystal medium
JP6326140B2 (ja) 2014-08-27 2018-05-16 富士フイルム株式会社 化合物、組成物、膜、光学機器
WO2016041877A1 (en) 2014-09-15 2016-03-24 Medivir Ab Methods for the preparation of diastereomerically pure phosphoramidate prodrugs
EP3212201B1 (en) 2014-10-28 2022-10-19 BCI Pharma Nucleoside kinase inhibitors
TWI687432B (zh) 2014-10-29 2020-03-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
US20170334941A1 (en) 2014-10-31 2017-11-23 Cocrystal Pharma, Inc. 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
US20170343847A1 (en) 2014-11-06 2017-11-30 Merck Patent Gmbh Light modulation element
US20170369780A1 (en) 2014-11-11 2017-12-28 Merck Patent Gmbh Bimesogenic compounds and mesogenic media
CN105646629A (zh) 2014-11-25 2016-06-08 广州市恒诺康医药科技有限公司 L-核苷类化合物及其应用
CN105777580B (zh) 2014-12-18 2018-05-18 湖南化工研究院有限公司 酰基乙腈类化合物及其制备方法与应用
MA41213A (fr) 2014-12-19 2017-10-24 Alios Biopharma Inc Nucléosides substitués, nucléotides et analogues de ceux-ci
EP3234689B1 (en) 2014-12-19 2020-01-29 Merck Patent GmbH Light modulation element
MA41441A (fr) 2014-12-19 2017-12-12 Alios Biopharma Inc Nucléosides substitués, nucléotides et analogues de ceux-ci
WO2016107664A1 (en) 2014-12-30 2016-07-07 Merck Patent Gmbh Bimesogenic compounds and mesogenic media
US20160237106A1 (en) 2015-01-14 2016-08-18 Riboscience Llc 4'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replication
WO2016116508A1 (de) 2015-01-20 2016-07-28 Cynora Gmbh Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen
CN107109233A (zh) 2015-01-20 2017-08-29 捷恩智株式会社 液晶组合物及液晶显示元件
EP3048159B1 (en) 2015-01-22 2019-08-07 Merck Patent GmbH Liquid crystal medium
WO2016116254A1 (en) 2015-01-23 2016-07-28 Merck Patent Gmbh Light modulation element
US20180004045A1 (en) 2015-01-23 2018-01-04 Merck Patent Gmbh Light modulation element
KR102539268B1 (ko) 2015-02-10 2023-06-07 메르크 파텐트 게엠베하 액정 매질
JP6485106B2 (ja) 2015-02-24 2019-03-20 Jnc株式会社 液晶組成物および液晶表示素子
WO2016145142A1 (en) 2015-03-10 2016-09-15 Emory University Nucleotide and nucleoside therapeutics compositions and uses related thereto
KR20160110900A (ko) 2015-03-13 2016-09-22 메르크 파텐트 게엠베하 액정 매질
KR102587314B1 (ko) 2015-03-13 2023-10-12 메르크 파텐트 게엠베하 액정 매질
JP6325171B2 (ja) 2015-03-17 2018-05-16 富士フイルム株式会社 有機半導体組成物、及び、有機半導体素子の製造方法
JP6870609B2 (ja) 2015-03-24 2021-05-12 Jnc株式会社 液晶組成物および液晶表示素子
US20180271873A1 (en) 2015-04-01 2018-09-27 The California Institute For Biomedical Research Methods for treating viral infections
FR3034767A1 (fr) 2015-04-07 2016-10-14 Centre Nat Rech Scient Reduction des fonctions carbonyles de glucides et derives de glucides en milieu aqueux par le dithionite de sodium
US10479940B2 (en) 2015-04-23 2019-11-19 Jnc Corporation Liquid crystal composition and liquid crystal display device
WO2016172631A2 (en) 2015-04-24 2016-10-27 President And Fellows Of Harvard College Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
CN107709344B (zh) 2015-05-01 2022-07-15 共晶制药股份有限公司 用于治疗黄病毒科病毒和癌症的核苷类似物
CN106279322B (zh) 2015-05-15 2019-07-30 上海唐润医药科技有限公司 抗丙肝病毒的核苷类化合物及其应用
DE102015210388A1 (de) 2015-06-05 2016-12-08 Siemens Aktiengesellschaft Organische Heterozyklische Alkalimetallsalze als n-Dotierstoffe in der Organischen Elektronik
ES2744775T3 (es) 2015-07-06 2020-02-26 Bayer Cropscience Ag Heterociclos que contienen nitrógeno como pesticidas
WO2017019817A1 (en) 2015-07-29 2017-02-02 Medivation Technologies, Inc. Methods and compositions for targeted therapeutics
WO2017019822A1 (en) 2015-07-29 2017-02-02 Medivation Technologies, Inc. Pellet composition containing repair cells
WO2017019830A1 (en) 2015-07-29 2017-02-02 Medivation Technologies, Inc. Methods and compositions for targeted therapeutics
WO2017023894A1 (en) 2015-08-03 2017-02-09 Raze Therapeutics, Inc. Mthfd2 inhibitors and uses thereof
CN108026136A (zh) 2015-08-06 2018-05-11 奇默里克斯公司 作为有用的抗病毒剂的吡咯并嘧啶核苷及其类似物
US10738074B2 (en) 2015-08-13 2020-08-11 Merck Sharp & Dohme Corp. Cyclic di-nucleotide compounds as STING agonists
TWI730980B (zh) 2015-08-26 2021-06-21 比利時商健生藥品公司 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
KR20180051582A (ko) 2015-09-09 2018-05-16 메르크 파텐트 게엠베하 액정 매질
CN106518766A (zh) 2015-09-11 2017-03-22 中国人民解放军军事医学科学院毒物药物研究所 新型二芳基脲类化合物,其制备方法及其医药用途
CN106518767A (zh) 2015-09-11 2017-03-22 中国人民解放军军事医学科学院毒物药物研究所 取代苯并吡唑二芳基脲类化合物,其制备方法及其医药用途
JP2018532869A (ja) 2015-09-15 2018-11-08 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ホメオトロピック配向を有する液晶媒体
BR112018005048B8 (pt) 2015-09-16 2021-03-23 Gilead Sciences Inc uso de um composto antiviral ou sal do mesmo para o tratamento de uma infecção por coronaviridae
CN105218523B (zh) 2015-09-18 2019-08-23 上海吉铠医药科技有限公司 吡啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
CN105254624B (zh) 2015-09-18 2019-08-09 上海吉铠医药科技有限公司 异噻唑衍生物pim激酶抑制剂及其制备方法与在制药中的应用
CN105130959B (zh) 2015-09-18 2018-08-03 上海吉铠医药科技有限公司 嘧啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
US10875842B2 (en) 2015-09-28 2020-12-29 Araxes Pharma Llc Inhibitors of KRAS G12C mutant proteins
AU2016331955B2 (en) 2015-09-30 2022-07-21 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
WO2017066797A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Trinucleotide mrna cap analogs
EP3362460A1 (en) 2015-10-16 2018-08-22 Modernatx, Inc. Mrna cap analogs and methods of mrna capping
ES2914225T3 (es) 2015-10-16 2022-06-08 Modernatx Inc Análogos de cap de ARNm con enlace de fosfato modificado
WO2017066782A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Hydrophobic mrna cap analogs
WO2017066791A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Sugar substituted mrna cap analogs
WO2017068875A1 (ja) 2015-10-23 2017-04-27 Jnc株式会社 液晶組成物および液晶表示素子
CN107108498B (zh) 2015-10-26 2020-08-21 株式会社Lg化学 胺化合物和包含其的有机发光元件
WO2017073933A1 (ko) 2015-10-26 2017-05-04 주식회사 엘지화학 스피로형 화합물 및 이를 포함하는 유기 발광 소자
WO2017073931A1 (ko) 2015-10-28 2017-05-04 주식회사 엘지화학 스피로형 화합물 및 이를 포함하는 유기 발광 소자
US11191774B2 (en) 2015-11-25 2021-12-07 The Regents Of The University Of California Drug formulations for cancer treatment
EP3383874A1 (de) 2015-12-03 2018-10-10 Bayer CropScience Aktiengesellschaft Mesolonische halogenierte 3-(acetyl)-1-[(1,3-thiazol-5-yl)methyl]-1h-imidazo[1,2-a]pyridin-4-ium-2-olat derivate und verwandte verbindungen als insektizide
CN108368424B (zh) 2015-12-11 2022-06-03 默克专利股份有限公司 可聚合化合物及其在液晶显示器中的用途
CN106892920B (zh) 2015-12-18 2019-12-13 中国医学科学院医药生物技术研究所 苦豆碱衍生物、其制备方法及用途
KR102419178B1 (ko) 2015-12-29 2022-07-11 삼성디스플레이 주식회사 유기 발광 소자
TWI740910B (zh) 2016-03-09 2021-10-01 美商艾洛斯生物製藥公司 非環抗病毒劑
WO2017153186A1 (en) 2016-03-10 2017-09-14 Janssen Pharmaceutica Nv Substituted nucleoside analogues for use as prmt5 inhibitors
MX2018011105A (es) 2016-03-16 2018-11-22 Kura Oncology Inc Inhibidores sustituidos de menina-mll y metodos de uso.
WO2017165489A1 (en) 2016-03-23 2017-09-28 Emory University Antiviral agents for treating zika and dengue virus infections
CN107286190A (zh) 2016-04-13 2017-10-24 刘沛 核苷之烃氧基苄基氨基磷酸/膦酸酯衍生物的制备及其医药用途
WO2017184668A1 (en) 2016-04-20 2017-10-26 Gilead Sciences, Inc. Methods for treating flaviviridae virus infections
CA3026196A1 (en) 2016-06-01 2017-12-07 Queen's University At Kingston Etching metal using n-heterocyclic carbenes
GB201609600D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Cancer treatments
WO2018015323A2 (en) 2016-07-20 2018-01-25 Merck Patent Gmbh Switching layer for use in an optical switching element
CN109890831A (zh) 2016-08-12 2019-06-14 詹森生物制药有限公司 被取代的核苷、核苷酸以及它们的类似物
JP2018044028A (ja) 2016-09-12 2018-03-22 オルガノサイエンス株式会社 液晶組成物
WO2018067615A1 (en) 2016-10-03 2018-04-12 Sigilon Therapeutics, Inc. Compounds, devices, and uses thereof
WO2018065356A1 (en) 2016-10-05 2018-04-12 Merck Patent Gmbh Organic semiconducting compounds
WO2018098206A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2018106820A1 (en) 2016-12-07 2018-06-14 Kura Oncology, Inc. Methods of promoting beta cell proliferation
WO2018106818A1 (en) 2016-12-07 2018-06-14 Kura Oncology, Inc. Methods of promoting beta cell proliferation
JP6551618B2 (ja) 2016-12-16 2019-07-31 Dic株式会社 表示素子用封止材料組成物、及び、それを用いた表示素子
JP6547912B2 (ja) 2016-12-19 2019-07-24 Dic株式会社 重合性組成物、及び、それを用いた光学異方体
WO2018119263A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds derivatives as pd-l1 internalization inducers
EP3573718B1 (en) 2017-01-27 2022-06-01 Janssen Biotech, Inc. Cyclic dinucleotides as sting agonists
US12089486B2 (en) 2017-02-08 2024-09-10 Universal Display Corporation Organic electroluminescent materials and devices
EP4331677A3 (en) 2017-03-14 2024-05-29 Gilead Sciences, Inc. Methods of treating feline coronavirus infections
US11944627B2 (en) 2017-03-24 2024-04-02 Kura Oncology, Inc. Methods for treating hematological malignancies and Ewing's sarcoma
WO2018183635A1 (en) 2017-03-31 2018-10-04 Peloton Therapeutics, Inc. Cd73 inhibitors and uses thereof
ES2919474T3 (es) 2017-04-07 2022-07-26 Medshine Discovery Inc Derivado de [1,2,4]triazolo[1,5-c]pirimidina como inhibidor del receptor A2A
EP3609977B1 (de) 2017-04-13 2024-05-29 Merck Patent GmbH Zusammensetzung für organische elektronische vorrichtungen
US10836787B2 (en) 2017-05-01 2020-11-17 Gilead Sciences, Inc. Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
WO2018208667A1 (en) 2017-05-12 2018-11-15 Merck Sharp & Dohme Corp. Cyclic di-nucleotide compounds as sting agonists
WO2018213185A1 (en) 2017-05-17 2018-11-22 Drexel University Rela inhibitors for biofilm disruption
AU2018272065B2 (en) 2017-05-25 2020-08-13 Hyconix, Inc. Direct oxidation of olefins to oxygenated species
US10004719B1 (en) 2017-05-30 2018-06-26 Taigen Biotechnology Co., Ltd. Solid dispersion formulation
WO2018222172A1 (en) 2017-05-30 2018-12-06 Taigen Biotechnology Co., Ltd. Solid dispersion formulation
AU2018276305A1 (en) 2017-05-31 2019-12-19 Commonwealth Scientific And Industrial Research Organisation Inhibiting hydrocarbon hydrate agglomeration
US11542248B2 (en) 2017-06-08 2023-01-03 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with MLL proteins
JP2018203945A (ja) 2017-06-08 2018-12-27 Dic株式会社 重合性液晶組成物、及び、それを用いた光学異方体
EP3642182A4 (en) 2017-06-21 2020-12-09 Wave Life Sciences Ltd. COMPOUNDS, COMPOSITIONS AND SYNTHESIS METHODS
WO2019014247A1 (en) 2017-07-11 2019-01-17 Gilead Sciences, Inc. COMPOSITIONS COMPRISING POLYMERASE RNA INHIBITOR AND CYCLODEXTRIN FOR THE TREATMENT OF VIRAL INFECTIONS
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
DK3678668T3 (da) 2017-09-08 2024-04-08 Univ Leland Stanford Junior ENPP1-inhibitorer og deres anvendelse til behandling af kræft
CN111094298A (zh) 2017-09-13 2020-05-01 默克专利股份有限公司 有机半导体化合物
AU2018332540B2 (en) 2017-09-18 2023-10-05 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
KR20190041918A (ko) 2017-10-13 2019-04-23 메르크 파텐트 게엠베하 액정 매질
EP3700527A4 (en) 2017-10-25 2021-03-10 Children's Medical Center Corporation PAPD5 INHIBITORS AND THEIR METHODS OF USE
WO2019086400A1 (en) 2017-11-02 2019-05-09 Merck Patent Gmbh Organic semiconducting compounds
CN109748944B (zh) 2017-11-03 2021-12-10 中国科学院上海药物研究所 5’-脱氧-5’-异丙基取代氨基核苷类化合物、其制备方法和用途
CN109748943A (zh) 2017-11-03 2019-05-14 中国科学院上海药物研究所 2’-c-甲基取代核苷类化合物及其制备与用途
CN109748921B (zh) 2017-11-03 2022-03-22 中国科学院上海药物研究所 N-叔丁氧羰基保护的杂环类化合物、其制备方法及其用于制备c-核苷类似物的方法
WO2019092171A1 (en) 2017-11-09 2019-05-16 Inflazome Limited Novel sulfonamide carboxamide compounds
JP7207321B2 (ja) 2017-11-16 2023-01-18 Jsr株式会社 レジスト下層膜形成用組成物、レジスト下層膜及びその形成方法、パターニングされた基板の製造方法並びに化合物
US11685761B2 (en) 2017-12-20 2023-06-27 Merck Sharp & Dohme Llc Cyclic di-nucleotide compounds as sting agonists
EP3502210B1 (en) 2017-12-20 2020-09-09 Merck Patent GmbH Liquid-crystal medium
EP3502209B1 (en) 2017-12-20 2020-10-14 Merck Patent GmbH Liquid-crystalline media having homeotropic alignment
KR20190076339A (ko) 2017-12-22 2019-07-02 한미약품 주식회사 신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
CA3087192A1 (en) 2017-12-27 2019-07-04 Raymond F. Schinazi Combined modalities for nucleosides and/or nadph oxidase (nox) inhibitors as myeloid-specific antiviral agents
CN111094317B (zh) 2017-12-29 2023-03-31 上海和誉生物医药科技有限公司 一种具有cd73抑制活性的膦酸衍生物、其制备方法和应用
JP2019137753A (ja) 2018-02-08 2019-08-22 シャープ株式会社 液晶組成物および液晶ディスプレイ
EP3749649A1 (en) 2018-02-08 2020-12-16 ENYO Pharma Non-fused thiophene derivatives and their uses
JP7417530B2 (ja) 2018-03-09 2024-01-18 アーカス バイオサイエンシズ インコーポレイティド 優先投与される免疫増強薬
CN108276352B (zh) 2018-03-13 2022-09-20 华东理工大学 一种具有杀线虫活性的含氮杂环化合物及其制法和用途
WO2019195056A1 (en) 2018-04-04 2019-10-10 Sigilon Therapeutics, Inc. Methods, compositions, and implantable elements comprising stem cells
WO2019215076A1 (de) 2018-05-08 2019-11-14 Bayer Aktiengesellschaft Verfahren zur herstellung stickstoffhaltiger heterocyclen
CN108727344A (zh) 2018-05-14 2018-11-02 嘉兴特科罗生物科技有限公司 一种化合物及其合成方法和应用
US11945803B2 (en) 2018-08-07 2024-04-02 Tosk, Inc. Modulators of RAS GTPase
WO2020032152A1 (ja) 2018-08-09 2020-02-13 ヤマサ醤油株式会社 4'-置換ヌクレオシド誘導体の立体選択的合成法
CN110215456A (zh) 2019-06-25 2019-09-10 华中农业大学 一种由gc376与gs-441524组成的猫冠状病毒抑制剂组合物
CN110330540A (zh) 2019-08-08 2019-10-15 木天(济南)生物科技有限公司 核苷盐及其制备方法
CN110724174B (zh) 2019-09-10 2021-02-05 广州六顺生物科技股份有限公司 吡咯并三嗪类化合物、组合物及其应用
CN110776512A (zh) 2019-11-28 2020-02-11 成都傲飞生物化学品有限责任公司 一种核苷类似物的制备方法
JP7429799B2 (ja) 2020-02-18 2024-02-08 ギリアード サイエンシーズ, インコーポレイテッド 抗ウイルス化合物
TWI791193B (zh) 2020-02-18 2023-02-01 美商基利科學股份有限公司 抗病毒化合物
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
CN111620909B (zh) * 2020-06-05 2022-12-02 广东中科药物研究有限公司 一种瑞德西韦的前体药物及其制备方法与应用

Also Published As

Publication number Publication date
AU2021221986A1 (en) 2022-08-18
TW202322824A (zh) 2023-06-16
CN115087659A (zh) 2022-09-20
US20210284670A1 (en) 2021-09-16
US11767337B2 (en) 2023-09-26
AU2023270323A1 (en) 2023-12-14
KR20220142483A (ko) 2022-10-21
WO2021168038A1 (en) 2021-08-26
JP2023514335A (ja) 2023-04-05
US20240174704A1 (en) 2024-05-30
JP2024015041A (ja) 2024-02-01
AU2021221986B2 (en) 2023-09-07
TWI794742B (zh) 2023-03-01
TW202143981A (zh) 2021-12-01
CA3171497A1 (en) 2021-08-26
JP7483023B2 (ja) 2024-05-14
EP4107164A1 (en) 2022-12-28

Similar Documents

Publication Publication Date Title
AR121355A1 (es) Compuestos antivirales
AR121356A1 (es) Compuestos antivirales
AR091976A1 (es) Inhibidores de proteasa ns3 de vhc
AR122902A2 (es) Compuestos terapéuticamente activos y sus métodos de preparación
AR113909A1 (es) Compuestos y sus composiciones farmacéuticas para el tratamiento de hepatitis b
AR084976A1 (es) Compuestos de bifenileno sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
AR117102A1 (es) Inhibidores de arg1 y/o arg2
AR057872A1 (es) Inhibidores de la proteina activadora de 5-lipoxigenasa (flap)
AR106945A2 (es) Compuestos de isoindolina y composiciones farmacéuticas de los mismos
AR047981A1 (es) Inhibidores de caspasa y sus usos correspondientes
AR098136A1 (es) Compuestos de heteroarilo como inhibidores de btk y usos de los mismos
AR088352A1 (es) Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
AR062050A1 (es) Derivados de amina utiles como agentes anti-cancerigenos
AR102467A1 (es) Métodos para tratar infecciones por el virus filoviridae
CO6160232A2 (es) Derivados de bencimidazol
AR119010A1 (es) Compuestos, composiciones y métodos de uso
CY1113450T1 (el) Διαμινοπυριμιδινες ως ρ2χ3 και ρ2χ2/3 ανταγωνιστες
DOP2011000048A (es) Derivados de purina para usarse en el tratamiento de enfermedades alergicas, inflamatorias e infecciosas
AR094262A1 (es) Compuestos antivirales para el tratamiento de la hepatitis c
CY1116254T1 (el) Νεα 4-αμινο-4-οξοβουτανοϋλ πεπτιδια ως αναστολεις ιϊκης αντιγραφης
CO6390122A2 (es) Activadores novedosos de glucocinasa y metodos de uso de los mismos
ECSP066414A (es) Derivados de malonamida que bloquean la actividad de gama-secretasa
AR104555A1 (es) SULFONAS TRICÍCLICAS COMO MODULARES DE RORg
AR058287A1 (es) Derivados de isoquinolina y composicion farmaceutica
AR086546A1 (es) Derivados de 7h-purin-8(9h)-ona como inhibidores de jak